New testing method can diagnose COVID-19 in just 30 minutes, study finds

OCT 06, 2020 SEOUL: Scientists have developed a new method that allows anyone to easily and quickly detect COVID-19 in just 30 minutes, and is as accurate as the current PCR diagnostic test. The SENSR technology developed by researchers at Pohang University of Science & Technology (POSTECH) in South Korea diagnosis COVID-19 based on the RNA sequence of the virus, reducing the stress on one single testing location and avoiding contact with infected patients as much as possible. RNA is a nucleic acid that mediates genetic information or is involved in controlling the expression of genes. The biggest benefit is that a diagnostic kit can be developed within a week even if a new infectious disease appears other than COVID-19, according to the research published in the journal Nature Biomedical Engineering. The researchers noted that PCR molecular test currently used for COVID-19 diagnosis has very high accuracy but entails a complex preparation process to extract or refine the virus. The test is not suitable for use in small farming or fishing villages, or airport or drive-thru screening clinics as it requires expensive equipment as well as skilled experts, they said. The researchers designed the test kit to produce nucleic acid binding reaction to show fluorescence only when COVID-19 RNA is present. The virus can be detected immediately...
Read More........

Blood serum from animals can slash Covid severity: ICMR

The Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based pharmaceuticals and biologics company, has introduced a well-established treatment modality to control the severity of COVID-19 disease, the apex research institute informed on Thursday."The ICMR along with Biological E. Limited have developed "highly purified antisera (raised in animals) for prophylaxis and treatment of the viral disease," it said.Antisera are blood serum derived from animals which contain antibodies against specific antigens. They are injected to treat or protect against specific diseases. After plasma therapy, it is the latest therapy to be used to treat and prevent the severity of COVID-19 disease among the patients.While plasma therapy could not derive a satisfactory result in reducing mortality of the severe patients of COVID-19, the ICMR has high hopes riding on the antisera therapy. "Although, plasma recovered from patients experiencing COVID-19 could serve a similar purpose, the profile of antibodies, their efficacy and concentration keep varying from one patient to another and therefore make it an unreliable clinical tool for patient management," the ICMR stated.However, the therapeutic use of antisera is not new to medical science. The ICMR said that it has been used to control many viral and bacterial infections. Besides,...
Read More........